Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
RareCan selected for Francis Crick Institute KQ Labs data-driven health accelerator programme
7 December 2022
Cambridge Angels
RareCan selected for Francis Crick Institute KQ Labs data-driven health accelerator programme
Cambridge Angels
7 December 2022

RareCan selected for Francis Crick Institute KQ Labs data-driven health accelerator programme

Cambridge Angels
7 December 2022

Source:https://rarecan.com/pioneering-rare-cancer-research-platform-selected-for-francis-crick-institute-kq-labs-data-driven-health-accelerator-programme/

Newer PostThought Machine signs Brazillian digital bank C6
Older PostNova Pangaea sets up base at Sembcorp's Wilton site
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net